{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:50:31Z","timestamp":1776513031178,"version":"3.51.2"},"reference-count":16,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1248\/bpb.b20-00361","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T22:14:01Z","timestamp":1601504041000},"page":"1600-1603","source":"Crossref","is-referenced-by-count":6,"title":["Effects of Concomitant Administration of Vonoprazan Fumarate on the Tacrolimus Blood Concentration in Kidney Transplant Recipients"],"prefix":"10.1248","volume":"43","author":[{"given":"Takanori","family":"Mei","sequence":"first","affiliation":[{"name":"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitaka","family":"Suetsugu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kyushu University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hisadome","sequence":"additional","affiliation":[{"name":"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Kaku","sequence":"additional","affiliation":[{"name":"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Okabe","sequence":"additional","affiliation":[{"name":"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satohiro","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, International University of Health and Welfare Narita Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Sugano K. Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date. Ther. Adv. Gastroenterol.<\/i>, 11<\/b>, 1756283X17745776 (2018)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Echizen H. The first-in-class potassium-competitive acid blocker, vonoprazan fumarate: Pharmacokinetics and pharmacodynamic considerations. Clin. Pharmacokinet.<\/i>, 55<\/b>, 409\u2013418 (2016).","DOI":"10.1007\/s40262-015-0326-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Shapiro R, Jordan ML, Scantlebury VP, Vivas C, Fung JJ, McCauley J, Randhawa P, Demetris AJ, Irish W, Mitchell S, Hakala TR, Simmons RL, Starzl TE. A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation<\/i>, 59<\/b>, 485\u2013490 (1995).","DOI":"10.1097\/00007890-199502270-00007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Iwasaki K. Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab. Pharmacokinet.<\/i>, 22<\/b>, 328\u2013335 (2007).","DOI":"10.2133\/dmpk.22.328"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Itagaki F, Homma M, Yuzawa K, Nishimura M, Naito S, Ueda N, Ohkohchi N, Kohda Y. Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations. J. Pharm. Pharmacol.<\/i>, 56<\/b>, 1055\u20131059 (2004).","DOI":"10.1211\/0022357043914"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Isoda K, Takeuchi T, Kotani T, Hirano-Kuwata S, Shoda T, Hata K, Yoshida S, Makino S, Hanafusa T. The proton pump inhibitor lansoprazole, but not rabeprazole, the increased blood concentrations of calcineurin inhibitors in Japanese patients with connective tissue diseases. Intern. Med.<\/i>, 53<\/b>, 1413\u20131418 (2014).","DOI":"10.2169\/internalmedicine.53.2394"},{"key":"7","unstructured":"7) Kotani K, Maekawa M, Kanno T. Reestimation of aspartate aminotransferase (AST)\/alanine aminotransferase (ALT) ratio based on JSCC consensus method\u2014changes of criteria for a differential diagnosis of hepatic disorders following the alteration from Karmen method to JSCC method. Nihon Shokakibyo Gakkai Zasshi<\/i>, 91<\/b>, 154\u2013161 (1994)."},{"key":"8","unstructured":"8) e-IF (Pharmaceutical Interview Forms). Pharmaceuticals and Medical Devices Agency.: \u2039https:\/\/www.pmda.go.jp\/english\/index.html\u203a, Approved in December 2014. Revised October 2019."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis.<\/i>, 53<\/b>, 982\u2013992 (2009).","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Wang Y, Wang C, Wang S, Zhou Q, Dai D, Shi J, Xu X, Luo Q. Cytochrome P450-based drug\u2013drug interactions of vonoprazan in vitro<\/i> and in vivo.<\/i> Front. Pharmacol.<\/i>, 11<\/b>, 53 (2020).","DOI":"10.3389\/fphar.2020.00053"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Wang X, Lee WYW, Zhou X, Or PMY, Yeung JHK. A pharmacodynamic-pharmacokinetic (PD\u2013PK) study on the effects of Danshen (Salvia miltiorrhiza<\/i>) on midazolam, a model CYP3A probe substrate, in the rat. Phytomedicine<\/i>, 17<\/b>, 876\u2013883 (2010).","DOI":"10.1016\/j.phymed.2010.05.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Takahashi K, Motohashi H, Yonezawa A, Okuda M, Ito N, Yamamoto S, Ogawa O, Inui K. Lansoprazole\u2013tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism. Ann. Pharmacother.<\/i>, 38<\/b>, 791\u2013794 (2004).","DOI":"10.1345\/aph.1D366"},{"key":"13","unstructured":"13) Brunet M, van Gelder T, Asberg A, et al.<\/i> Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther. Drug Monit.<\/i>, 41<\/b>, 261\u2013307 (2019)."},{"key":"14","unstructured":"14) Sugimoto M, Ban H, Hira D, Kamiya T, Otsuka T, Inatomi O, Bamba S, Terada T, Andoh A. Letter: CYP3A4<\/i>\/5<\/i> genotype status and outcome of vonoprazan-containing Helicobacter pylori<\/i> eradication therapy in Japan. Aliment. Pharmacol. Ther.<\/i>, 45<\/b>, 1009\u20131010 (2017)."},{"key":"15","unstructured":"15) Touw DJ. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes. Drug Metabol. Drug Interact.<\/i>, 14<\/b>, 55\u201382 (1997)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yamasaki H, Kawaguchi N, Nonaka M, Takahashi J, Morohashi A, Hirabayashi H, Moriwaki T, Asahi S. In vitro<\/i> metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker. Xenobiotica<\/i>, 47<\/b>, 1027\u20131034 (2017).","DOI":"10.1080\/00498254.2016.1203505"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/10\/43_b20-00361\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:14:05Z","timestamp":1601694845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/10\/43_b20-00361\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00361","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}